STORY FROM: Hip & Knee Implant Litigation

Biomet Plaintiffs’ Committee Says M2a-Taper Claims Should be Remanded, Are Designed ‘Significantly’ Different

SOUTH BEND, Ind. –– The plaintiffs’ executive committee has filed a position statement in the Biomet M2a Magnum Hip Implant coordinated docket, insisting that the defendant’s M2a-Taper products should be remanded since it is a different device than that of the Magnum or M2a 38 implants.

In a Dec. 9 memorandum of the status conference, the U.S. District Court for the Northern District of Indiana noted that it had requested the written statement during a Dec. 7 status conference.

According to the Dec. 9 filing, the MDL Court also addressed, and heard arguments relating to, the proposed scheduling order ...

Associated Documents
Memorandum
Brief



Registered User Login

Username

Password


Related Conferences

No conferences scheduled at this time.




Full Archives

True